TrivarX Limited
MDBIF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.37 | 0.07 | 0.02 | -0.00 |
| FCF Yield | -0.88% | -48.09% | -74.83% | -110.74% |
| EV / EBITDA | -20.17 | -4.60 | -1.65 | -1.29 |
| Quality | ||||
| ROIC | 1.00% | -21.36% | 0.19% | -7.03% |
| Gross Margin | 100.00% | -10.48% | -120.17% | 99.89% |
| Cash Conversion Ratio | 0.17 | 0.69 | 0.35 | 0.14 |
| Growth | ||||
| Revenue 3-Year CAGR | 5.54% | -4.03% | -8.74% | 96.02% |
| Free Cash Flow Growth | 95.17% | -4.95% | 33.08% | -34.97% |
| Safety | ||||
| Net Debt / EBITDA | 1.26 | 0.62 | 0.04 | 0.37 |
| Interest Coverage | 3.81 | -157.44 | 1.36 | -58.01 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -3,676.31 | -421.34 | -341,555.40 |